In the past few years, multispecific antibodies, such as trispecific, bispecific, and tetraspecific, have become popular in antibody therapeutics. Compared to conventional monospecific antibodies ...

RevOpsis says it is committed to the rapid discovery and development of novel multispecific therapies utilizing its modular ...

The funding is expected to support the development of a second novel multispecific antibody to SARS-CoV-2 from preclinical through Phase 1 trials, as well as preclinical work on gene-based ...

Ichnos launched with a running start in 2019 when it was spun-out as an innovation unit by generics leader Glenmark, and subsequently focused on developing novel multispecific antibody ...

(RTTNews) - AbbVie (ABBV) and EvolveImmune Therapeutics announced a collaboration and option-to-license agreement to develop multispecific biologics for multiple targets in oncology. The ...

Alec Nielsen, co-founder and CEO, Asimov Ramanath Bhandari, RevOpsis co-founder and CEO, commented: "RevOpsis is committed to the rapid discovery and development of novel multispecific therapies ...

Ramanath Bhandari, RevOpsis co-founder and CEO, commented: “RevOpsis is committed to the rapid discovery and development of novel multispecific therapies utilizing our modular RevMod™ Platform ...

Strategic agreement will accelerate the manufacturing of fully human multispecific therapies for chronic retinal diseases with high unmet need using Asimov’s CHO Edge System BOSTON & SAN CARLOS ...